510(k) Report

PMA · Approved

Approved

Ems Swiss Dolorclast

P050004PMAApproved May 8, 2007825-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Electro Medical Systems (Ems Sa) · NBN Generator, Shock-Wave, For Pain Relief

Approved on May 8, 2007 through premarket approval, which rests on the device’s own clinical evidence after an 825-day review.

Decided
May 8, 2007
Review
825 days
Class
Class III
Product code
NBN
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P050004 has 1 supplement since 2009: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2009: 1
2009high 1 (2009) · low 0 (2010)2010
View FIG. 1 as a table
YearSupplements approved
20091
FIG. 1 — Supplements to P050004, 2009–2009Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All NBN devices

NBN Generator, Shock-Wave, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · NBN

1in 2020

2007: 12009: 12016: 12020: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBN

Too few NBN 510(k)s in any year since 2007 to give a median.

Recalls per year · NBN

No recall names NBN since 2007.

Adverse event reports per year · NBN

1in 2025

2007: 12008: 12009: 22010: 12013: 12025: 1
2007high 2 (2009) · low 0 (2011)2025

MAUDE reports naming product code NBN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
20080—01
20091—02
20100—01
20110—00
20120—00
20130—01
20140—00
20150—00
20161—00
20170—00
20180—00
20190—00
20201—00
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—
Cite this page

510(k) Report. “P050004: Ems Swiss Dolorclast.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/P050004

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026